Ignite Creation Date:
2025-12-25 @ 12:08 AM
Ignite Modification Date:
2025-12-29 @ 4:47 PM
Study NCT ID:
NCT06642558
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-06-06
First Post:
2024-10-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Healthy Subjects Aged 18 Years and Above
Sponsor:
MAXVAX Biotechnology Limited Liability Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-11-13
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-02-28
Completion Date Type:
ESTIMATED
First Submit Date:
2024-10-11
First Submit QC Date:
None
Study First Post Date:
2024-10-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-04
Last Update Post Date:
2025-06-06
Last Update Post Date Type:
ACTUAL